The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours-Reference-Cited by-同舟云学术

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

Published:2018-03-22 Issue:1 Volume:20 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

El Ansari Rokaya,Craze Madeleine L.,Miligy Islam,Diez-Rodriguez Maria,Nolan Christopher C.,Ellis Ian O.,Rakha Emad A.,Green Andrew R.^ORCID

Funder

University of Nottingham

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-018-0946-6.pdf

Reference55 articles.

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

2. Bond P. Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance. J Int Soc Sports Nutr. 2016;13:8.

3. Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014;24(7):400–6.

4. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458(7239):762–5.

5. Hayashi K, Jutabha P, Endou H, Anzai N. c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Oncol Rep. 2012;28(3):862–6.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional characterization of the SDR42E1 reveals its role in vitamin D biosynthesis;Heliyon;2024-09

2. The role of the ALKBH5 RNA demethylase in invasive breast cancer;Discover Oncology;2024-08-11

3. Conserved role of FOXC1 in TNBC is parallel to FOXA1 in ER+ breast cancer;iScience;2024-08

4. SLC7A5 is required for citrulline-dependent growth in arginine limited conditions;2024-06-28

5. ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer;Pathobiology;2024-06-11